Todd Franklin Watanabe - 10 Jun 2025 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Officer, Director
Signature
/s/ Latha Vairavan, Attorney-in-Fact for Todd Franklin Watanabe
Issuer symbol
ARQT
Transactions as of
10 Jun 2025
Transactions value $
$0
Form type
4
Filing time
12 Jun 2025, 16:53:13 UTC
Previous filing
05 May 2025
Next filing
05 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Watanabe Todd Franklin Officer, Director C/O ARCUTIS BIOTHERAPEUTICS, INC., 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE /s/ Latha Vairavan, Attorney-in-Fact for Todd Franklin Watanabe 12 Jun 2025 0001801061

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARQT Common Stock Gift $0 -997 -0.11% $0.00 914K 10 Jun 2025 Direct F1
transaction ARQT Common Stock Gift $0 +997 +4.08% $0.00 25.4K 10 Jun 2025 By Trust F2, F3
transaction ARQT Common Stock Gift $0 -997 -0.11% $0.00 913K 10 Jun 2025 Direct
transaction ARQT Common Stock Gift $0 +997 +4.08% $0.00 25.4K 10 Jun 2025 By Trust F3, F4
holding ARQT Common Stock 57.4K 10 Jun 2025 By LLC F3, F5
holding ARQT Common Stock 125K 10 Jun 2025 By Trust F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,315 shares purchased under Arcutis Biotherapeutics, Inc. Employee Stock Purchase Plan on May 31, 2025.
F2 The securities are held of record by The John Franklin Watanabe Irrevocable Trust, of which the Reporting Person is the trustee.
F3 The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of these securities for purposes of Section 16 or for any other purposes.
F4 The securities are held of record by The Anderson Prest Watanabe Irrevocable Trust, of which the Reporting Person is the trustee.
F5 The securities are held of record by Watanabe Ventures, LLC, of which the Reporting Person is the Chief Operating Officer.
F6 The securities are held of record by The Watanabe 2016 Irrevocable Trust, of which the Reporting Person's children are beneficiaries.

Remarks:

Reporting Person's title: President and Chief Executive Officer; Exhibit List: Exhibit 24.1 - Power of Attorney